Unum Group (UNM)
(Real Time Quote from BATS)
$55.38 USD
+0.59 (1.08%)
Updated Aug 28, 2024 11:30 AM ET
2-Buy of 5 2
A Value F Growth B Momentum B VGM
Unum (UNM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$61.67 | $70.00 | $52.00 | 12.56% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Unum comes to $61.67. The forecasts range from a low of $52.00 to a high of $70.00. The average price target represents an increase of 12.56% from the last closing price of $54.79.
Analyst Price Targets (12)
Broker Rating
Unum currently has an average brokerage recommendation (ABR) of 2.07 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 2.07 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, seven are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 50% and 7.14% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 7.14%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/UNM.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 5 | 5 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 5 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 2.07 | 2.07 | 2.07 | 2.25 | 2.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/12/2024 | Wells Fargo Securities | Elyse Greenspan | Strong Buy | Strong Buy |
8/1/2024 | Truist Securities | Mark D Hughes | Strong Buy | Strong Buy |
7/23/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/11/2024 | Piper Sandler | John Barnidge | Not Available | Strong Buy |
7/9/2024 | Dowling & Partners | Joel Hurwitz | Not Available | Strong Buy |
6/26/2024 | Evercore Partners | Thomas Gallagher | Hold | Hold |
6/12/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/2/2024 | Keefe Bruyette & Woods | Ryan Krueger | Moderate Buy | Moderate Buy |
4/8/2024 | Not Identified | Not Identified | Not Available | Strong Sell |
2/20/2024 | Not Identified | Not Identified | Hold | Hold |
1/31/2024 | Goldman Sachs | Alex Scott | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.07 |
ABR (Last week) | 2.07 |
# of Recs in ABR | 14 |
Average Target Price | $61.67 |
LT Growth Rate | 8.60% |
Industry | Insurance - Accident and Health |
Industry Rank by ABR | 53 of 253 |
Current Quarter EPS Est: | 2.10 |